Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The fatty acid binding protein FABP7 is required for optimal oligodendrocyte differentiation during myelination but not during remyelination.

Autor: Foerster, Sarah, Guzman de la Fuente, Alerie, Kagawa, Yoshiteru, Bartels, Theresa, Owada, Yuji, Franklin, Robin J. M.

Publikováno v: Glia; Jul2020, Vol. 68 Issue 7, p1410-1420, 11p

Pericytes Favor Oligodendrocyte Fate Choice in Adult Neural Stem Cells

Autor: Silva, Maria Elena, Lange, Simona, Hinrichsen, Bryan, Philp, Amber R, Reyes, Carolina R, Halabi, Diego, Mansilla, Josselyne B, Rotheneichner, Peter, Guzman De La Fuente, Alerie, Couillard-Despres, Sebastien, Bátiz, Luis F, Franklin, Robin JM, Aigner, Ludwig, Rivera, Francisco J

Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). Upon demyelination, oligodendrocyte progenitor cells (OPCs) are activated and they proliferate, migrate and differentiate into myelin-producing olig

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c5c1c680117b34a30cc27296bde7ff08

The microbiota regulates murine inflammatory responses to toxin-induced CNS demyelination but has minimal impact on remyelination.

Autor: McMurran CE; Wellcome-MRC Stem Cell Institute, University of Cambridge, CB2 0AW Cambridge, United Kingdom., Guzman de la Fuente A; Wellcome-MRC Stem Cell Institute, University of Cambridge, CB2 0AW Cambridge, United Kingdom.; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, BT9 7BL Belfast, United Kingdom., Penalva R; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, BT9 7BL Belfast, United Kingdom., Ben Menachem-Zidon O; Wellcome-MRC Stem Cell Institute, University of Cambridge, CB2 0AW Cambridge, United Kingdom.; Hadassah Human Embryonic Stem Cell Research Center, Goldyne Savad Institute of Gene Therapy, Hadassah-Hebrew University Hospital, 91240 Jerusalem, Israel., Dombrowski Y; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, BT9 7BL Belfast, United Kingdom., Falconer J; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, BT9 7BL Belfast, United Kingdom., Gonzalez GA; Wellcome-MRC Stem Cell Institute, University of Cambridge, CB2 0AW Cambridge, United Kingdom., Zhao C; Wellcome-MRC Stem Cell Institute, University of Cambridge, CB2 0AW Cambridge, United Kingdom., Krause FN; Department of Biochemistry, University of Cambridge, CB2 1GA Cambridge, United Kingdom., Young AMH; Wellcome-MRC Stem Cell Institute, University of Cambridge, CB2 0AW Cambridge, United Kingdom., Griffin JL; Department of Biochemistry, University of Cambridge, CB2 1GA Cambridge, United Kingdom., Jones CA; Respiratory, Inflammation and Autoimmunity Research, MedImmune Ltd., CB21 6GH Cambridge, United Kingdom., Hollins C; Respiratory, Inflammation and Autoimmunity Research, MedImmune Ltd., CB21 6GH Cambridge, United Kingdom., Heimesaat MM; Institute for Microbiology, Infectious Diseases and Immunology, Charité-University Medicine Berlin, 14195 Berlin, Germany., Fitzgerald DC; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, BT9 7BL Belfast, United Kingdom; d.fitzgerald@qub.ac.uk rjf1000@cam.ac.uk., Franklin RJM; Wellcome-MRC Stem Cell Institute, University of Cambridge, CB2 0AW Cambridge, United Kingdom; d.fitzgerald@qub.ac.uk rjf1000@cam.ac.uk.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2019 Dec 10; Vol. 116 (50), pp. 25311-25321. Date of Electronic Publication: 2019 Nov 18.